80
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Selenium Reduces Enterohemorrhagic Escherichia Coli O157:H7 Verotoxin Production and Globotriaosylceramide Receptor Expression on Host Cells

, , , , &
Pages 745-756 | Received 27 Nov 2015, Accepted 22 Mar 2016, Published online: 18 May 2016

References

  • Scharff RL. Economic burden from health losses due to foodborne illness in the United States. J. Food Prot. 75, 123 – 131 (2012).
  • Naylor SW, Low JC, Besser TE et al. Lymphoid follicle-dense mucosa at the terminal rectum is the principal site of colonization of enterohemorrhagic Escherichia coli O157:H7 in the bovine host. Infect. Immun. 71, 1505 – 1512 (2003).
  • Sakagami Y, Murata H, Nakanishi T et al. Inhibitory effect of plant extracts on production of verotoxin by Enterohemorrhagic Escherichia coli O157:H7. J. Health Sci. 47, 473 – 477 (2001).
  • Weeratna RD, Doyle MP. Detection and production of verotoxin 1 of Escherichia coli O157:H7 in food. Appl. Environ. Microbiol. 57, 2951 – 2955 (1991).
  • Smith HR, Gross RJ, Rowe B, Fry NK, Scotland SM. Hemorrhagic colitis and Vero-cytotoxin-producing Escherichia coli in England and Wales. Lancet 329, 1062 – 1065 (1987).
  • Yuk HG, Marshall DL. Heat adaptation alters Escherichia coli O157: H7 membrane lipid composition and verotoxin production. Appl. Environ. Microbiol. 69 (9 ), 5115 – 5119 (2003).
  • Yuk HG, Marshall DL. Adaptation of Escherichia coli O157: H7 to pH alters membrane lipid composition, verotoxin secretion, and resistance to simulated gastric fluid acid. Appl. Environ. Microbiol. 70 (6 ), 3500 – 3505 (2004).
  • Yuk HG, Marshall DL. Effect of trisodium phosphate adaptation on changes in membrane lipid composition, verotoxin secretion, and acid resistance of Escherichia coli O157: H7 in simulated gastric fluid. Int. J. Food Microbiol. 106 (1 ), 39 – 44 (2006).
  • Zhang X, Aaron DM, Lucas EW, Gerald TK, Matthew KW, David WKA. Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J. Infect. Dis. 181 (2 ), 664 – 670 (2000).
  • Matsushiro A, Sato K, Miyamoto H, Yamamura T, Honda T. Induction of prophages of enterohemorrhagic Escherichia coli O157: H7 with norfloxacin. J. Bacteriol. 181 (7 ), 2257 – 2260 (1999).
  • Neely MN, Friedman DI. Functional and genetic analysis of regulatory regions of coliphage H-19B: location of Shiga-like toxin and lysis genes suggest a role for phage functions in toxin release. Mol. Microbiol. 28 (6 ), 1255 – 1267 (1998).
  • Goldwater PN, Bettelheim KA. Treatment of enterohemorrhagic Escherichia coli (EHEC) infection and hemolytic uremic syndrome (HUS). BMC Med. 10 (1 ), 12 (2012).
  • Pacheco AR, Sperandio V. Shiga toxin in enterohemorrhagic E. coli: regulation and novel anti-virulence strategies. Front. Cell Infect. Microbiol. 2, 81 (2012).
  • Cilmi SA, Karalius BJ, Choy W, Smith RN, Butterton JR. Fabry disease in mice protects against lethal disease caused by Shiga toxin-expressing enterohemorrhagic Escherichia coli. J. Infect Dis. 194 (8 ), 1135 – 1140 (2006).
  • Lemire JA, Harrison JJ, Turner RJ. Antimicrobial activity of metals: mechanisms, molecular targets and applications. Nat. Rev. Microbiol. 11 (6 ), 371 – 384 (2013).
  • Lemire JA, Kalan L, Bradu A, Turner RJ. Silver oxynitrate: an unexplored silver compound with antimicrobial and antibiofilm activity. Antimicrob. Agents Chemother. 59 (7 ), 4031 – 4039 (2015).
  • Warnes SL, Caves V, Keevil CW. Mechanism of copper surface toxicity in Escherichia coli O157: H7 and Salmonella involves immediate membrane depolarization followed by slower rate of DNA destruction which differs from that observed for Gram-positive bacteria. Environ. Microbiol. 14 (7 ), 1730 – 1743 (2012).
  • Wakshlak RBK, Pedahzur R, Avnir D. Antibacterial activity of silver-killed bacteria: the ‘zombies’ effect. Sci. Rep. 5, 9555 (2015).
  • Crane JK, Byrd IW, Boedeker EC. Virulence inhibition by zinc in Shiga toxigenic Escherichia coli. Infect. Immun. 79 (4 ), 1696 – 1705 (2011).
  • Mukhopadhyay S, Linstedt AD. Manganese blocks intracellular trafficking of Shiga toxin and protects against Shiga toxicosis. Science 335 (6066 ), 332 – 335 (2012).
  • Rayman MP. The importance of selenium to human health. Lancet 356, 233 – 241 (2000).
  • Kryukov GV, Castellano S, Novoselov SV et al. Characterization of mammalian selenoproteomes. Science 300, 1439 – 1443 (2003).
  • El-Bayoumy K. The protective role of selenium on genetic damage and on cancer. Mutat. Res. 475, 123 – 139 (2001).
  • NIH. Selenium, dietary supplement fact sheet. Office of Dietary Supplements (2013). http://ods.od.nih.gov/factsheets/Selenium-HealthProfessional
  • Rayman MP. Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc. Nutr. Soc. 64, 527 – 542 (2005).
  • Rayman MP. Selenium and human health. Lancet 379, 1256 – 1268 (2012).
  • Soriano-Garcia M. Organoselenium compounds as potential therapeutic and chemopreventive agents: a review. Curr. Med. Chem. 11, 1657 – 1669 (2004).
  • Kumar BS, Tiwari SK, Manoj G et al. Anti-unlcer and antimicrobial activities of sodium selenite against Helicobacter pylori: in vitro and in vivo evaluation. Scand. J. Infect. Dis. 42, 266 – 274 (2010).
  • Johny AK, Hoagland T, Venkitanarayanan K. Effect of sub-inhibitory concentrations of plant-derived molecules in increasing the sensitivity of multidrug-resistant Salmonella entericaserovar typhimurium DT104 to antibiotics. Foodborne Pathog. Dis. 7, 1165 – 1170 (2010).
  • Staples M, Jennison AV, Graham R, Smith HV. Evaluation of the Meridian Premier EHEC assay as an indicator of Shiga toxin presence in direct fecal specimens. Diagn. Micr. Infec. Dis. 73, 322 – 325 (2012).
  • Pollard DR, Johnson WM, Lior H, Tyler SD, Rozee KR. Rapid and specific detection of verotoxin genes in Escherichia coli by the polymerase chain reaction. J. Clin. Microbiol. 28, 540 – 545 (1990).
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCt Method. Methods 25, 402 – 408 (2001).
  • Furukawa K, Yokoyama K, Sato T et al. Expression of the Gb3/CD77 synthase gene in megakaryoblastic leukemia cells implication in the sensitivity to verotoxins. J. Biol. Chem. 277, 11247 – 11254 (2002).
  • Tétaud C, Falguières T, Carlier K et al. Two distinct Gb3/CD77 signaling pathways leading to apoptosis are triggered by anti-Gb3/CD77 mAb and verotoxin-1. J. Biol. Chem. 278, 45200 – 45208 (2003).
  • Engedal N, Skotland T, Torgersen ML, Sandvig K. Shiga toxin and its use in targeted cancer therapy and imaging. Microb. Biotechnol. 4, 32 – 46 (2011).
  • Desselle A, Chaumette T, Gaugler MH et al. Anti-gb3 monoclonal antibody inhibits angiogenesis and tumor development. PLoS ONE 7 (11 ), e45423 (2012).
  • Keeney M, Gratama JW, Chin-Yee IH, Sutherlan DR. Isotype controls in the analysis of lymphocytes and CD34+ stem and progenitor cells by flow cytometry – time to let go! Cytometry 34 (6 ), 280 – 283 (1998).
  • Herzenberg LA, Tung J, Mooren WA, Herzenberg L, Parks DR. Interpreting flow cytometry data: a guide for the perplexed. Nat. Immunol. 7, 681 – 685 (2006).
  • Hughes AK, Stricklett PK, Schmid D, Kohan DE. Cytotoxic effect of Shiga toxin-1 on human glomerular epithelial cells 1. Kidney Int. 57 (6 ), 2350 – 2359 (2000).
  • Ashkenazi S, Cleary TG. Rapid method to detect Shiga toxin and Shiga-like toxin I based on binding to globotriosyl ceramide (Gb3), their natural receptor. J. Clin. Microbiol. 27 (6 ), 1145 – 1150 (1989).
  • Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolytic – uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N. Engl. J. Med. 342, 1930 – 1936 (2000).
  • Karch H, Tarr PI, Bielaszewska M. Enterohaemorrhagic Escherichia coli in human medicine. Int. J. Med. Microbiol. 295, 405 – 418 (2005).
  • Szu SC, Ahmed A. Clinical studies of Escherichia coli O157: H7 conjugate vaccines in adults and young children. Microbiol. Spectr. 2, 6 (2014).
  • Rasko DA, Sperandio V. Anti-virulence strategies to combat bacteria-mediated disease. Nat. Rev. Drug. Discov. 9, 117 – 128 (2010).
  • Khodaverdian V, Pesho M, Truit B et al. Discovery of anti-virulence agents against methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 57, 3645 – 3652 (2013).
  • Hung DT, Shakhnovich EA, Pierson E, Mekalanos JJ. Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization. Science 310, 670 – 674 (2005).
  • Cegelski L, Marshall GR, Eldridge GR, Hultgren SJ. The biology and future prospects of antivirulence therapies. Nat. Rev. Microbiol. 6, 17 – 27 (2008).
  • Mellbye B, Schuster M. The socio-microbiology of antivirulence drug resistance: a proof of concept. mBio 2 (5 ), pii: e00131-11 (2011).
  • Okuda T, Tokuda N, Numata SI et al. Targeted disruption of Gb3/CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to verotoxins. J. Biol. Chem. 281, 10230 – 10235 (2006).
  • Sandvig K, Garred O, Prydz K, Kozlov JV, Hansen SH, van Deurs B. Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum. Nature 510 – 512 (1992).
  • Sandvig K, Ryd M, Garred O, Schweda E, Holm PK, van Deurs B. Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and cAMP. J. Cell. Biol. 126, 53 – 64 (1994).
  • Sandvig K. Shiga toxins. Toxicon 39 (11 ), 1629 – 1635 (2001).
  • Jacewicz MS, Mobassaleh M, Gross SK et al. Pathogenesis of Shigella diarrhea: XVII. A mammalian cell membrane glycolipid, Gb3, is required but not sufficient to confer sensitivity to Shiga toxin. J. Infect. Dis. 169, 538 – 546 (1994).
  • Lingwood CA. Verotoxin-binding in human renal sections. Nephron. 66, 21 – 28 (1994).
  • Johansson D, Kosovac E, Moharer J. Expression of verotoxin-1 receptor Gb3 in breast cancer tissue and verotoxin-1 signal transduction to apoptosis. BMC Cancer 9, 67 (2009).
  • Lee L, Abe A, Shayman JA. Improved inhibitors of glucosylceramide synthase. J. Biol. Chem. 274, 14662 – 14669 (1999).
  • Silberstein C, Copeland DP, Chiang W-L, Repetto HA, Ibarra C. A glucosylceramide synthase inhibitor prevents the cytotoxic effects of Shiga toxin-2 on human renal tubular epithelial cells. J. Epithel. Biol. Pharmacol. 1, 71 – 75 (2008).
  • Kim EY, Zeng QT, Kuo FC, Rawn J, Mentzer SJ. Visual representation of cell subpopulation from flow cytometry data. AMIA Annu. Symp. Proc. 2003, 893 (2003).
  • Pharaboz MO, Cordier G, Andre J. Flow cytometry analysis of cells dispersed from the MtTF4 tumor whose growth is inhibited by estradiol treatment. Mol. Cell. Endocrinol. 48, 229 – 237 (1986).
  • Hughes AK, Ergonul Z, Stricklett PK, Kohan DE. Molecular basis for high renal cell sensitivity to the cytotoxic effects of Shigatoxin-1: up regulation of globotriaosyl ceramide expression. J. Nephrol. 13, 2239 – 2245 (2002).
  • National Academy of Science. Dietary reference intake (DRI) report (2000). www.nal.usda.gov/fnic/DRI//DRI_Vitamin_C/284–324_150.pdf
  • Sunde RA. Selenium. In : Modern Nutrition in Health and Disease (11th Edition). Ross AC, Caballero B, Cousins RJ, Tucker KL, Ziegler TR( Eds ) . Lippincott Williams & Wilkins, Philadelphia, PA, USA, 225 – 237 (2012).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.